The fungus Aspergillus fumigatus is the main pathogenic agent responsible for invasive
pulmonary aspergillosis. Immunocompromised patients are more likely to develop this …

The application of antimicrobial stewardship principles to immunocompromised patients is
feasible, necessary, and urgent. As antimicrobial stewardship programs gain momentum …

Background Invasive fungal infections (IFIs) are life‐threatening opportunistic infections that
occur in immunocompromised or critically ill people. Early detection and treatment of IFIs is …

Detection of serum galactomannan (GM) and (1, 3)‐β‐d‐glucan (BG) is considered useful
for non‐culture diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients …

In addition to being a vital organ for gas exchange, the lung is a crucial immune organ
continuously exposed to the external environment. Genetic defects that impair immune …

Background: The characteristics and management of invasive pulmonary aspergillosis (IPA)
in patients with hematologic malignancies are well known, but IPA in patients with solid …

Background. The pathogenesis of invasive aspergillosis (IA) is still unknown, but its
progression is rapid and mortality rate remains high. Bronchoalveolar lavage fluid (BALF) …

Invasive pulmonary aspergillosis (IPA) is a complication of influenza infection that has been
associated with 33-67% mortality (1-3). In a recent cohort of patients with severe …

Invasive fungal diseases are associated with significant morbidity and mortality, particularly
in immunocompromised individuals. Early and accurate diagnosis is crucial for effective …

Background: Serum galactomannan (GM) and β-D-glucan (BG) are known markers of
invasive aspergillosis (IA). The aim of this meta-analysis was to evaluate the efficiency of …